Calpol Infant Oral Suspension

Calpol is a well-known brand of children's medicine, specifically an oral suspension containing paracetamol. It was originally developed in the United Kingdom by Calmic Ltd, which was later acquired by Wellcome. The brand became a staple in British households for managing pain and fever in infants and children.

Over several decades, the ownership of the brand transitioned through several major pharmaceutical mergers, eventually becoming part of the Johnson & Johnson family. Currently, the brand is managed by Kenvue, which was spun off from Johnson & Johnson's consumer health division. The product is primarily manufactured in the United Kingdom to serve the British and European markets, though global supply chains may involve production in other international facilities.